|
The MCG system is the most accurate
means for non-invasive detection of heart
disease currently available. |
Recent News
February 11, 2010
Dr. Shen honored by Women's Heart Foundation
Dr. Shen was honored at the Women's Heart Foundation's Red Dress luncheon for his work in developing the Multifunction Cardiogram (MCG™) system. Women's Heart Foundation president and founder Bonnie Arkus stated "Dr. Shen's invention of the Multifunction CardioGram represents a major breakthrough in cardiology. … By recognizing Dr. Shen, we hope to raise awareness of ischemic heart disease and promote widespread use of the Multifunction CardioGram to save more hearts and more lives."
A copy of the press release is available here.
November 30, 2009
ICECBM/AAUCM Appropriateness Review
The Institute of Computational Electrophysiology and Clinical Biomathematics (ICECBM), in conjunction with the American Academy of Urgent Care Medicine (AAUCM), has conducted an appropriateness criteria review of Premier Heart's MCG technology for a variety of clinical indications and scenarios. The overall results of this review were very favorable toward MCG, particularly in patients with symptoms or signs of possible coronary artery disease (CAD).
A copy of the press release is available here.
November 9, 2009
MCG featured in Coding News
Premier Heart's MCG system was featured in Coding News: Hot Coding Topics – a CPT Code information digest.
The November 8th on-line article discusses MCG and other emerging Category III CPT codes for advanced diagnostic services in cardiology.
An excerpt from the article can be downloaded Here.
The full article is available from the Coding News Website.
September 30, 2009
Premier Heart Launches MCG in Latin America and the Caribbean
Premier Heart is pleased to announce the launch of Premier Heart CICA, a new division to launch and support our MCG technology in Latin America and the Caribbean.
Please see the press release for additional information.
July 13, 2009
Premier Heart announces availability of MCG
Premier Heart is pleased to announce the availability of the Multifunction Cardiogram (MCG™), the evolution of our groundbreaking 3DMP technology. MCG delivers unparalleled diagnostic accuracy through a non-invasive pain, stress, and radiation-free test.
Please see the press release for additional information.
July 2, 2009
AMA releases Category III CPT code for MCG
Premier Heart is pleased to announce the release of our Category III CPT code in the July 2009 CPT update. This code will be used for insurance reporting and reimbursement as well as tracking adoption of MCG to substantiate "widespread use" for our Category I code application.
MCG has been assigned the coding identifier 0206T, which will be implemented for use beginning January 1, 2010.
Premier Heart has issued a formal press release on the availability of MCG and our new CPT code.
Please see the press release for additional information.
A copy of the AMA CPT update is available here.
May 1, 2009
Clinical Trial Meta-Analysis Published
Premier Heart is pleased to announce the publication of our clinical trial meta-analysis, compiling data from our peer-reviewed studies conducted at leading heart centers around the world.
The meta-analysis article has been published in the April edition of the
International Journal of Medical Sciences, and is available in the
Clinical Trials
section of our website, or via
this
direct link.
January 26, 2009
Premier Heart Japan Launched
The Premier Heart International Sales team is pleased to
announce the official launch of Premier Heart Japan, our full-service division
handling the Asia-Pacific region.
We are currently seeking regulatory approval for clinical use in Japan, however
the Premier Heart Japan team will begin distributing units to The Philippines
later this year.
December 30, 2008
Premier Heart adds Florida to our map
Premier Heart is pleased to announce that we have shipped
our first 3DMP field unit to MIMA, a network of physicians in Florida's Brevard County.
This deployment comes after the 3DMP system proved its value in an on-site demonstration, assisting the MIMA staff with a particularly difficult diagnosis.
December 2, 2008
Premier Heart Asia - 3DMP goes on tour
Premier Heart is actively preparing to launch our 3DMP/mfEMT technology in the Asia-Pacific market in 2009. As part of this process we have opened communication with medical device distributors and physicians in Japan, where the 3DMP/mfEMT technology has received a warm reception.
I think the ischemia diagnosis mechanism developed by Dr. Joseph Shen is really ground-breaking as a very useful tool for the diagnosis of ischemic heart disease, which is on the rise in Japan. . . . Moreover, I am highly interested in its utility not only in stable but also unstable angina and NSTEMI.
| | — Dr. Kazuko Tajiri, M.D., Ph.D.
Department of Cardiovascular and Internal Medicine
Tsukuba University. |
Click here for archived news items
|
